Medicare Benefits Schedule - Item 73337

Search Results for Item 73337

Category 6 - PATHOLOGY SERVICES

73337

73337 - Additional Information

Item Start Date:
01-Jan-2014
Description Start Date:
01-Jul-2018
Schedule Fee Start Date:
01-Jan-2014

Group
P7 - Genetics

A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to erlotinib, gefitinib or afatinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled.

Fee: $397.35 Benefit: 75% = $298.05 85% = $337.75


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change